Careviso is a technology company.
Careviso has raised $17.0M across 1 funding round.
Careviso has raised $17.0M in total across 1 funding round.
Careviso has raised $17.0M in total across 1 funding round.
Careviso's investors include Ballast Point Ventures.
Careviso is a healthcare technology company founded in 2017 that builds seeQer, a transparency platform automating real-time insurance eligibility verification, prior authorization processing, and out-of-pocket cost estimation for healthcare providers.[1][2][3] It serves providers, administrators, and billing staff by solving administrative inefficiencies—like manual verification delays and errors—that cause care delays, higher costs, and patient dissatisfaction, while empowering patients with cost transparency.[1][3][4] Careviso has raised over $30M in funding, processes over 2M verifications, enrolls 200K+ providers, achieves >90% automation rates, and saves providers 300K+ hours annually, demonstrating strong growth momentum amid rising U.S. healthcare transparency demands.[1][3][5]
Careviso was founded in 2017 in Falls Church, VA, by co-founder and Chief Business Officer Perry Dimas, alongside leadership including Chief Operating and Financial Officer John Pavlovich.[1][5] The idea emerged from addressing core pain points in U.S. healthcare administration, such as opaque insurance processes and prior authorization hurdles that block patient access to care.[1][2] Early traction built through seeQer's integration with EHR systems and partnerships with tech firms, leading to milestones like 200,000 enrolled providers by April 2024 and launches of features like Coordination of Benefits and Patient Health Plan Discovery.[3][5] Backed by investors including Ballast Point, Mercury Fund, and Lytical Ventures, Careviso scaled by focusing on compliant, evolving software for a fragmented industry.[5][6]
Careviso rides the wave of healthcare price transparency and interoperability mandates, accelerated by laws like the Lower Costs, More Transparency Act and upcoming 2026 Interoperability rules, which demand real-time data sharing amid rising admin costs (30% of U.S. healthcare spend).[3] Timing aligns with AI adoption in prior auth and payer-provider tensions, where manual processes cause 94% of providers to report delays; seeQer counters this by automating eBV and GFEs, enabling digital transformation.[1][3] It influences the ecosystem by partnering with tech firms, showcasing at events like HLTH Da Vinci Connectathon, and supporting molecular diagnostics access, fostering a shift toward patient-centered, efficient care in a $4T+ market.[3][5]
Careviso is poised for expansion with seeQer's roadmap targeting AI enhancements, broader payer integrations, and compliance with 2026 interoperability rules, potentially doubling provider adoption amid regulatory tailwinds.[3] Trends like AI in prior auth and value-based care will amplify its edge, while pre-IPO status via platforms like EquityZen signals investor interest in its $30M+-funded trajectory.[5][6] As administrative burdens persist, Careviso's real-time transparency could redefine provider efficiency, evolving from a niche tool to an industry standard that truly unlocks patient access in U.S. healthcare.[1][2]
Careviso has raised $17.0M across 1 funding round. Most recently, it raised $17.0M Series B in September 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 1, 2022 | $17.0M Series B | Ballast Point Ventures |